Search results
7 lip 2021 · This guideline is based on evidence up to 2019 regarding the treatment of liver cirrhosis and supports clinical practice by presenting the contents of medical treatment that can be recommended and proposed.
- PMC Free Article
Introduction: sarcopenia 2018. In 2010, the European Working...
- Carvedilol Versus Traditional, Non‐Selective Beta‐Blockers for Adults With Cirrhosis and Gastroesophageal Varices
Overall, carvedilol appears to be as efficacious and safe as...
- Results of Portosystemic Shunt Embolization in Selected Patients With Cirrhosis and Recurrent Hepatic Encephalopathy
Some of the patients with early-stage cirrhosis experience...
- Antacids for Preventing Oesophagogastric Variceal Bleeding and Rebleeding in Cirrhotic Patients
Background. Ruptured gastroesophageal varices are the most...
- 410K
The definition of the metabolic syndrome (MetS) was based on...
- PubMed
EASL Clinical Practice Guidelines for the management of...
- PMC Free Article
guidance on the management of decompensated cirrhosis with the only purpose of improving clinical practice. 2018 European Association for the Study of the Liver.
treatment of cirrhosis, variceal bleeding, ascites, and hepatic en-cephalopathy. Six years after the publication of the 2011 guide-lines, the need arose to revise the guidelines for liver cirrhosis based on new evidence accumulated. Therefore, KASL revised the KASL clinical practice guidelines for liver cirrhosis: Ascites and related complications
This guideline is based on evidence up to 2019 regard-ing the treatment of liver cirrhosis and supports clinical practice by presenting the contents of medical treatment that can be recommended and proposed. The disease states of patients with cirrhosis are extremely diverse, and some medical treatment methods are outside the scope of insur-
16 paź 2020 · These guidelines are based on a comprehensive literature search and comprise systematic reviews in the key areas, including the diagnostic tests, diuretic use, therapeutic paracentesis, use of albumin, transjugular intrahepatic portosystemic stent shunt, spontaneous bacterial peritonitis and beta-blockers in patients with ascites.
15 paź 2020 · These guidelines are based on a comprehensive literature search and comprise systematic reviews in the key areas, including the diagnostic tests, diuretic use, therapeutic paracentesis, use of albumin, transjugular intrahepatic portosystemic stent shunt, spontaneous bacterial peritonitis and beta- blockers in patients with ascites.
25 sie 2016 · Owing to the increasing prevalence of nonalcoholic fatty liver disease, cirrhosis related to nonalcoholic steatohepatitis is predicted to surpass HCV-related cirrhosis as the most common...
